filip1987 schreef op 26 augustus 2015 22:05:
CMS Advisory Panel's Unanimous Vote to Maintain Medicare Reimbursement Rate for Cologuard
MADISON, Wis. --(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously to maintain Medicare's current crosswalk pricing ( $492.72 ) for Cologuard. The 11-0 vote, including one abstention, came after the Clinical Lab Fee Schedule's July 16, 2015 public meeting. Exact Sciences' Chairman and CEO Kevin Conroy presented a proposal at the July 16th meeting to crosswalk Cologuard from its current G-code to a CPT code. Following today's vote, Conroy issued this statement:
"We're very pleased with the panel's unanimous vote in favor of maintaining the current Medicare reimbursement for rate for Cologuard. CMS will post a preliminary determination after considering the July meeting comments, today's panel vote, and other written comments. A final determination is expected to be released in the November timeframe and will be effective January 1 , 2016."